The GA4GH is uniting researchers worldwide to share genomic data responsibly, set open standards, and improve oncology care ...

23andMe Research Institute, Troper Wojcicki Philanthropies (TWP), and Lifebit today announced the official launch of an open-source data platform for the Lung Cancer Genetics Study. Launched in 2024, ...

OncotypeDx offers another example of potential harm when not considering basic demographics in large-scale data set analyses. OncotypeDX is a clinical test used to recommend chemotherapy as part of ...

Over the past 50 years, multiple pathology organizations worldwide have evolved in cancer histopathology reporting from subjective, narrative assessments to structured, synoptic formats using ...

A new website offers a prototype for online access to an analytical toolbox that enables biomedical researchers to integrate dissimilar data from a variety of sources and extract the most useful ...

Genmab has shared the first data on rinatabart sesutecan (Rina-S) in advanced endometrial cancer. The biotech reported a 50% unconfirmed response rate, beating the expectations of William Blair ...

Susette Mueller led the Lombardi Comprehensive Cancer Center study that identified gene predictors of breast cancer survival rates. Researchers at the Georgetown Lombardi Comprehensive Cancer Center ...

The Inflation Reduction Act (IRA) of 2022 mandates price negotiations for certain drugs under Medicare, shortening the exclusivity period historically used to recoup research and development ...

Medical groups are expressing deep concern about the sudden removal or alteration of government data sets and webpages from ...

Medidata has supported the NCI Cancer Therapy Evaluation Program (CTEP) study portfolio with tools across the Medidata Platform for the past 17 years, strengthening the collaboration and reinforcing ...